RiboMed Biotechnologies Inc., a leading Epigenetics-Based Diagnostics company, today announced that the U.S. Patent and Trademark Office has issued three additional patents covering the use of their...
(PRWeb December 05, 2012)
Read the full story at http://www.prweb.com/releases/2012/12/prweb10199227.htm